Gilder Gagnon Howe & CO LLC Trans Medics Group, Inc. Transaction History
Gilder Gagnon Howe & CO LLC
- $8.39 Billion
- Q2 2025
A detailed history of Gilder Gagnon Howe & CO LLC transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Gilder Gagnon Howe & CO LLC holds 6,775 shares of TMDX stock, worth $812,322. This represents 0.01% of its overall portfolio holdings.
Number of Shares
6,775
Previous 5,859
15.63%
Holding current value
$812,322
Previous $394,000
130.2%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding TMDX
# of Institutions
421Shares Held
30MCall Options Held
1.19MPut Options Held
777K-
Vanguard Group Inc Valley Forge, PA3.6MShares$431 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$317 Million0.01% of portfolio
-
State Street Corp Boston, MA1.29MShares$155 Million0.01% of portfolio
-
Fil LTD Hamilton, D01.06MShares$127 Million0.13% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL956KShares$115 Million0.03% of portfolio
About TransMedics Group, Inc.
- Ticker TMDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 31,831,400
- Market Cap $3.82B
- Description
- TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...